Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M171Revenue (TTM) $M27.8Net Margin (%)-108.3Altman Z-Score-3.6
Enterprise Value $M98.5EPS (TTM) $-0.6Operating Margin %-111.1Piotroski F-Score3
P/E(ttm)--Beneish M-Score-4.3Pre-tax Margin (%)-108.3Higher ROA y-yY
Price/Book2.110-y EBITDA Growth Rate %--Quick Ratio4.3Cash flow > EarningsN
Price/Sales6.05-y EBITDA Growth Rate %-15.6Current Ratio4.3Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-15.1Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-33.6Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M50.4ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with INFI

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

INFI is held by these investors:



INFI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
VENUTI MICHAEL CDirector 2017-03-17Sell6,250$3.48-2.59view
BIOTECHNOLOGY VALUE FUND L P10% Owner 2017-01-03Buy4,379$1.34152.99view
BIOTECHNOLOGY VALUE FUND L P10% Owner 2016-12-30Buy742,401$1.34152.99view
BIOTECHNOLOGY VALUE FUND L P10% Owner 2016-12-20Buy654,921$1.31158.78view
KANGO SUJAYChief Commercial Officer 2016-12-13Sell75,000$1.28164.84view
BIOTECHNOLOGY VALUE FUND L P10% Owner 2016-12-02Buy201,394$1.19184.87view
Perkins Adelene QPresident & CEO 2015-06-25Sell5,000$10.93-68.98view
Palombella Vito J.Chief Scientific Officer 2015-06-15Sell4,737$10.97-69.1view
Perkins Adelene QPresident & CEO 2015-05-27Sell10,000$12.81-73.54view
Perkins Adelene QPresident & CEO 2015-05-14Sell10,000$12.18-72.17view

Quarterly/Annual Reports about INFI:

News about INFI:

Articles On GuruFocus.com
Pernix: An Investor's Rationale to Staying Long Mar 23 2017 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 04 2010 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) May 06 2010 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 06 2009 
Infinity Pharmaceuticals Inc. Reports Operating Results (10-Q) May 06 2009 

More From Other Websites
ETFs with exposure to Infinity Pharmaceuticals, Inc. : March 27, 2017 Mar 27 2017
3 Reasons Why Infinity Pharmaceuticals (INFI) is a Great Momentum Stock Mar 23 2017
Infinity Pharma Focuses on Cancer Drug: Competition Looms Mar 21 2017
Infinity Pharmaceuticals, Inc. :INFI-US: Earnings Analysis: 2016 By the Numbers : March 20, 2017 Mar 20 2017
INFINITY PHARMACEUTICALS, INC. Financials Mar 18 2017
Infinity (INFI) Reports Narrower-than-Expected Loss in Q4 Mar 15 2017
Infinity reports 4Q loss Mar 14 2017
Infinity reports 4Q loss Mar 14 2017
INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Mar 14 2017
Infinity Provides Company Update and Reports Fourth Quarter 2016 Financial Results Mar 14 2017
INFINITY PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report Mar 14 2017
Q4 2016 Infinity Pharmaceuticals Inc Earnings Release - After Market Close Mar 14 2017
IPI-549 Featured at 15th International Congress on Targeted Anticancer Therapies Mar 06 2017
Infinity Announces Presentation on IPI-549 at AACR Annual Meeting Mar 02 2017
Infinity Pharmaceuticals (INFI) Catches Eye: Stock Up 13.5% Mar 01 2017
Infinity Announces the Date of Its Full-Year 2016 Financial Results Conference Call and Webcast Feb 28 2017
Infinity to Present at 37th Annual Cowen and Company Healthcare Conference Feb 27 2017
Infinity Announces Promotion of Jeffery Kutok, M.D., Ph.D. to Chief Scientific Officer Feb 13 2017
Infinity to Present at the 2017 BIO CEO & Investor Conference Feb 06 2017
Faster FDA Approval Process Could Ignite These Biotech Stocks in 2017 Feb 02 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)